Infections, Toxic Chemicals and Dietary Peptides Binding to Lymphocyte Receptors and Tissue Enzymes are Major Instigators of Autoimmunity in Autism

Similar to many complex autoimmune diseases, genetic and environmental factors including diet, infection and xenobiotics play a critical role in the development of autism. In this study, we postulated that infectious agent antigens such as streptokinase, dietary peptides (gliadin and casein) and ethyl mercury (xenobiotic) bind to different lymphocyte receptors and tissue enzyme (DPP IV or CD26). We assessed this hypothesis first by measuring IgG, IgM and IgA antibodies against CD26, CD69, streptokinase (SK), gliadin and casein peptides and against ethyl mercury bound to human serum albumin in patients with autism. A significant percentage of children with autism developed anti-SK, anti-gliadin and casein peptides and anti-ethyl mercury antibodies, concomitant with the appearance of anti-CD26 and anti-CD69 autoantibodies. These antibodies are synthesized as a result of SK, gliadin, casein and ethyl mercury binding to CD26 and CD69, indicating that they are specific. Immune absorption demonstrated that only specific antigens, like CD26, were capable of significantly reducing serum anti-CD26 levels. However, for direct demonstration of SK, gliadin, casein and ethyl mercury to CD26 or CD69, microtiter wells were coated with CD26 or CD69 alone or in combination with SK, gliadin, casein or ethyl mercury and then reacted with enzyme labeled rabbit anti-CD26 or anti-CD69. Adding these molecules to CD26 or CD69 resulted in 28–86 % inhibition of CD26 or CD69 binding to anti-CD26 or anti-CD69 antibodies. The highest % binding of these antigens or peptides to CD26 or CD69 was attributed to SK and the lowest to casein peptides. We, therefore, propose that bacterial antigens (SK), dietary peptides (gliadin, casein) and Thimerosal (ethyl mercury) in individuals with pre-disposing HLA molecules, bind to CD26 or CD69 and induce antibodies against these molecules. In conclusion, this study is apparently the first to demonstrate that dietary peptides, bacterial toxins and xenobiotics bind to lymphocyte receptors and/or tissue enzymes, resulting in autoimmune reaction in children with autism.

[1]  A. Salama,et al.  Immune‐mediated agranulocytosis related to drugs and their metabolites: mode of sensitization and heterogeneity of antibodies , 1989, British journal of haematology.

[2]  B. Sachs,et al.  Allergic and autoimmune reactions to xenobiotics: how do they arise? , 1998, Immunology today.

[3]  M. Shamy,et al.  Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms. , 1999, Environmental health perspectives.

[4]  S. Pizzo,et al.  Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases. , 2001, Clinical and experimental rheumatology.

[5]  R. von Baehr,et al.  The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro , 1987, European journal of immunology.

[6]  Harumi Jyonouchi,et al.  Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression , 2001, Journal of Neuroimmunology.

[7]  C. Morimoto,et al.  Direct association of adenosine deaminase with a T cell activation antigen, CD26. , 1993, Science.

[8]  E. Anyanwu,et al.  Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A , 2002, Journal of Neuroimmunology.

[9]  M. Strauss,et al.  Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. , 1993, Journal of immunology.

[10]  P. Ruiz,et al.  Multicolor Cytoenzymatic Evaluation of Dipeptidyl Peptidase IV (CD26) Function in Normal and Neoplastic Human T-Lymphocyte Populations , 1998, Clinical Diagnostic Laboratory Immunology.

[11]  M. Otsuka,et al.  Anti-CD69 Autoantibodies Cross-React with Low Density Lipoprotein Receptor-Related Protein 2 in Systemic Autoimmune Diseases1 , 2001, The Journal of Immunology.

[12]  K. Imai,et al.  Cytokines stimulate dipeptidyl peptidase-IV expression on human luteinizing granulosa cells. , 1994, The Journal of clinical endocrinology and metabolism.

[13]  A. Kramer,et al.  Cross-reactivity of myelin basic protein-specific T cells with multiple microbial peptides: experimental autoimmune encephalomyelitis induction in TCR transgenic mice. , 1999, Journal of immunology.

[14]  B. McIntyre,et al.  Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation , 1991, Journal of cellular biochemistry.

[15]  H. Gérard,et al.  A Chlamydia pneumoniae-Specific Peptide Induces Experimental Autoimmune Encephalomyelitis in Rats1 , 2001, The Journal of Immunology.

[16]  D. Cantor,et al.  The neurotoxic etiology of the autistic spectrum disorders: a replication study , 2000 .

[17]  Limin Shi,et al.  Prenatal Viral Infection Leads to Pyramidal Cell Atrophy and Macrocephaly in Adulthood: Implications for Genesis of Autism and Schizophrenia , 2002, Cellular and Molecular Neurobiology.

[18]  J. Drijfhout,et al.  The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. , 2002, Gastroenterology.

[19]  J. Jover,et al.  Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T cells. , 1995, The Journal of rheumatology.

[20]  Paula A. Kiberstis,et al.  It's Not Just the Genes , 2002, Science.

[21]  A. Wakefield,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. , 1998, Lancet.

[22]  H. Satoh,et al.  The immunologic and metabolic basis of drug hypersensitivities. , 1988, Annual review of pharmacology and toxicology.

[23]  Limin Shi,et al.  Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring , 2003, The Journal of Neuroscience.

[24]  S. Ivarsson,et al.  Autism as one of several disabilities in two children with congenital cytomegalovirus infection. , 1990, Neuropediatrics.

[25]  A. Sabrá,et al.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children , 1998, The Lancet.

[26]  M. Bronze,et al.  Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. , 1993, Journal of immunology.

[27]  R. Gerli,et al.  Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients , 1994, Clinical and experimental immunology.

[28]  H. Wieser,et al.  Investigation of the putative immunodominant T cell epitopes in coeliac disease , 2003, Gut.

[29]  M. Lubinsky.  Behavioral consequences of congenital rubella. , 1979, The Journal of pediatrics.